IE43770L - Calcitonin preparations - Google Patents

Calcitonin preparations

Info

Publication number
IE43770L
IE43770L IE761101A IE110176A IE43770L IE 43770 L IE43770 L IE 43770L IE 761101 A IE761101 A IE 761101A IE 110176 A IE110176 A IE 110176A IE 43770 L IE43770 L IE 43770L
Authority
IE
Ireland
Prior art keywords
calcitonin
preparations
suspensions
prolonged action
peptide
Prior art date
Application number
IE761101A
Other versions
IE43770B1 (en
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IE43770L publication Critical patent/IE43770L/en
Publication of IE43770B1 publication Critical patent/IE43770B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Case 4-9910/+ CANADA PEPTIDE PREPARATIONS WITH PROLONGED ACTION The invention is directed to calcitonin preparations with prolonged action which are characterized by the presence of a calcitonin with hypocalcemic activity having an isoelectric point in the pH range of about 5 to 9, in the form of a suspension of the sparingly soluble free peptide base in an aqueous or oily liquid. There are used for instance suspensions of Calcitonin M or a derivative or analog thereof, preferably containing 0.1 to 5 mg/ml of the peptide base. The invention also includes a method for the treatment of pathological conditions in humans for whom the administration of a calcitonin is indicated, such as Paget's disease, by administering the suspensions of the invention by the subcutaneous or intramuscular route. [CA1098444A]
IE1101/76A 1975-05-26 1976-05-25 Calcitonin peptide preparations with prolonged action IE43770B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671975 1975-05-26

Publications (2)

Publication Number Publication Date
IE43770L true IE43770L (en) 1976-11-26
IE43770B1 IE43770B1 (en) 1981-05-20

Family

ID=4313966

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1101/76A IE43770B1 (en) 1975-05-26 1976-05-25 Calcitonin peptide preparations with prolonged action

Country Status (14)

Country Link
JP (1) JPS51144721A (en)
AU (1) AU507537B2 (en)
BE (1) BE842189A (en)
CA (1) CA1098444A (en)
DE (1) DE2623074A1 (en)
FR (1) FR2312260A1 (en)
GB (1) GB1548984A (en)
HK (1) HK15982A (en)
IE (1) IE43770B1 (en)
IL (1) IL49653A (en)
MY (1) MY8200284A (en)
NL (1) NL7605559A (en)
NZ (1) NZ180945A (en)
ZA (1) ZA763096B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
NL8701143A (en) * 1986-05-27 1987-12-16 Sandoz Ag PHARMACEUTICAL PREPARATIONS.
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
IT1255895B (en) * 1992-10-20 1995-11-17 Laura Chiodini PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
WO1999043300A1 (en) * 1998-02-25 1999-09-02 Abbott Laboratories Butorphanol sustained release formulations
WO2023089240A1 (en) * 2021-11-19 2023-05-25 Nanoform Finland Oyj A composition comprising nanosized active pharmaceutical ingredient

Also Published As

Publication number Publication date
FR2312260B1 (en) 1978-12-08
NZ180945A (en) 1978-07-10
IE43770B1 (en) 1981-05-20
JPS51144721A (en) 1976-12-13
HK15982A (en) 1982-04-08
AU507537B2 (en) 1980-02-21
AU1425276A (en) 1977-12-01
BE842189A (en) 1976-11-25
DE2623074A1 (en) 1976-12-09
NL7605559A (en) 1976-11-30
ZA763096B (en) 1978-01-25
IL49653A (en) 1979-07-25
GB1548984A (en) 1979-07-18
FR2312260A1 (en) 1976-12-24
IL49653A0 (en) 1976-07-30
CA1098444A (en) 1981-03-31
MY8200284A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
NO843002L (en) Aqueous solution containing a lipid-soluble pharmaceutical substance
NO307445B1 (en) Pharmaceutical preparations containing nanocapsules and processes for their preparation
IE43770L (en) Calcitonin preparations
ATE125706T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DIPHOSPHONATES FOR THE TREATMENT OF ARTHROSIS.
NO882239D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLIC PEPTIDES.
NO882238D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLIC PEPTIDES.
KR880008801A (en) Solution for parenteral administration
KR950005325A (en) Pharmaceutical composition
NO894880D0 (en) PROCEDURE FOR THE PREPARATION OF ANTICOAGULATING PEPTIDES.
EP0354418A3 (en) 6-fluoro-3,5-dihydroxycarboxylic acids and their derivatives, processes for their preparation, their use as medicaments, pharmaceutical preparations and intermediates
EP0241136A3 (en) Human class 1 heparin-binding growth factor
FI98891B (en) Procedure for raising the protein content in an aqueous solution
GB1475262A (en) Human urinary trypsin inhibitor and a method of preparing it
ES8303324A1 (en) Use of a substance obtained from blood serum for the stabilization of prostaglandins.
KR960000224A (en) Novel drugs containing 3,7-diazabicyclo [3, 3, 1] nonan-compounds
ATE412669T1 (en) CALICITONIN ANALOGS WITH HIGHLY INCREASED HYPOCALCEMIC EFFECTS IN VIVO
KR920002139A (en) Cerebrovascular Contraction
RU93005154A (en) PROCESSES, PHARMACEUTICAL COMPOSITION SYSTEMS